experspadmin

Novel Targets and Molecular Profiling in Prostate Cancer
Oncology

Novel Targets and Molecular Profiling in Prostate Cancer

expert roundtables
By Daniel J. George, MD; Oliver Sartor, MD; William K. Oh, MD
The Shift Toward Earlier Use of Life-Extending Therapies and Combinations in Advanced Prostate Cancer
Oncology

The Shift Toward Earlier Use of Life-Extending Therapies and Combinations in Advanced Prostate Cancer

expert roundtables
By Daniel J. George, MD; Glen Gejerman, MD; Oliver Sartor, MD; William K. Oh, MD
Monitoring Progression and Response to Prostate Cancer Therapy: A Composite Model
Oncology

Monitoring Progression and Response to Prostate Cancer Therapy: A Composite Model

expert roundtables
By Daniel J. George, MD; Glen Gejerman, MD; Oliver Sartor, MD; William K. Oh, MD
Oligometastatic Prostate Cancer: Can We Get to Cure?
Oncology

Oligometastatic Prostate Cancer: Can We Get to Cure?

expert roundtables
By Daniel J. George, MD; Glen Gejerman, MD; Oliver Sartor, MD; William K. Oh, MD
Assessing Rapid Treatment Response in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Oncology

Assessing Rapid Treatment Response in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)

clinical study insights
By Oliver Sartor, MD
Load More